Changing incidence patterns of hepatocellular carcinoma among age groups in Taiwan.

No abstract is available for this paper.

• Publication year

  2015

• Venue

  Journal of Hepatology

• Publication date

  2015-12-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/j.jhep.2015.07.032PMID 26256438
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Secular trends were considered in the evaluation of universal hepatitis B vaccination in Taiwan.

  2015cited by this paper
• Quality assessment and improvement of nationwide cancer registration system in Taiwan: a review.

  2015cited by this paper
• Significant reduction in end‐stage liver diseases burden through the national viral hepatitis therapy program in Taiwan

  2015influential reference
• Prevention of hepatitis B virus infection and liver cancer.

  2014cited by this paper
• Cancer incidence patterns among children and adolescents in Taiwan from 1995 to 2009: A population-based study

  2014cited by this paper
• Treatment for Hepatocellular Carcinoma in Elderly Patients: A Literature Review

  2013cited by this paper
• National Antiviral Treatment Program and the Incidence of Hepatocellular Carcinoma and Associated Mortality in Taiwan: A Preliminary Report

  2013cited by this paper
• GLOBOCAN 2012 v1.0, Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 11 [Internet]. Lyon, France: International Agency for Research on Cancer

  2013cited by this paper
• Thirty-year outcomes of the national hepatitis B immunization program in Taiwan.

  2013cited by this paper
• Heavy alcohol consumption increases the incidence of hepatocellular carcinoma in hepatitis B virus-related cirrhosis.

  2013cited by this paper
• Hepatocellular carcinoma in non-alcoholic fatty liver disease: an emerging menace.

  2012cited by this paper
• Medium Chain Fatty Acids Are Selective Peroxisome Proliferator Activated Receptor (PPAR) γ Activators and Pan-PPAR Partial Agonists

  2012cited by this paper
• Fifteen-Year Population Attributable Fractions and Causal Pies of Risk Factors for Newly Developed Hepatocellular Carcinomas in 11,801 Men in Taiwan

  2012cited by this paper
• Minimization of hepatitis B infection by a 25-year universal vaccination program.

  2012cited by this paper
• Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008

  2010cited by this paper
• The incidence and epidemiology of hepatocellular carcinoma: a global and regional perspective.

  2010cited by this paper
• Decreased incidence of hepatocellular carcinoma in hepatitis B vaccinees: a 20-year follow-up study.

  2009influential reference
• Geographic variations of predominantly hepatitis C virus associated male hepatocellular carcinoma townships in Taiwan: identification of potential high HCV endemic areas

  2009cited by this paper
• Metabolic factors and risk of hepatocellular carcinoma by chronic hepatitis B/C infection: a follow-up study in Taiwan.

  2008cited by this paper
• Body-mass index and progression of hepatitis B: a population-based cohort study in men.

  2008cited by this paper
• Hepatocellular carcinoma in Taiwan

  2007influential reference
• Taiwan's new national health insurance program: genesis and experience so far.

  2003cited by this paper
• Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults.

  2003cited by this paper
• Incidence and cofactors of hepatitis C virus-related hepatocellular carcinoma: a prospective study of 12,008 men in Taiwan.

  2003cited by this paper
• Overweight, obesity, and cancer risk.

  2002cited by this paper
• Kim H-J, Fay MP, Feuer EJ, Midthune DN, ‘ Permutation tests for joinpoint regression with applications to cancer rates’. Statistics in Medicine 2000 19:335–351

  2001cited by this paper
• Permutation tests for joinpoint regression with applications to cancer rates.

  2000cited by this paper
• Cancer Incidence in Five Continents

  1997cited by this paper
• Cancer registration: principles and methods. Statistical methods for registries.

  1991cited by this paper

• Global burden and trends of pelvic organ prolapse: an observational trend study from 1990 to 2021.

  2026cites this paper
• Global, regional, and national burden of early-onset and late-onset colorectal cancer attributable to high body-mass index from 1990 to 2021: a trend analysis and forecasts up to 2040 based on the global burden of disease study 2021

  2025cites this paper
• Global burden of disease analysis of stroke due to high systolic blood pressure in different regions, 1990–2021

  2025cites this paper
• Trend dynamics of mumps prevalence among children aged 1–9 years in Changzhou, 2005–2023: a joinpoint regression and age-period-cohort analysis

  2025cites this paper
• Global strategies and actions to eliminate hepatitis B virus infection

  2025cites this paper
• The Lancet Commission on addressing the global hepatocellular carcinoma burden: comprehensive strategies from prevention to treatment.

  2025cites this paper
• Epidemiological trends in abortion and miscarriage between 1990 and 2019

  2025cites this paper
• Global, regional and national burden of rheumatoid arthritis from 1990 to 2021, with projections of incidence to 2050: a systematic and comprehensive analysis of the Global Burden of Disease study 2021

  2025cites this paper
• Treatment for hepatocellular carcinoma after immunotherapy.

  2025cites this paper
• Exposure to high-temperature and high-humidity environments associated with cardiovascular mortality.

  2025cites this paper
• Prevention of liver cancer in the era of next-generation antivirals and obesity epidemic.

  2025cites this paper
• Significant reduction in Hepatitis B virus infections following 32 years of universal Hepatitis B vaccination as part of EPI, Thailand

  2025cites this paper
• Global, regional, national burden of asthma from 1990 to 2021, with projections of incidence to 2050: a systematic analysis of the global burden of disease study 2021

  2025cites this paper
• Global, regional, and national burdens of leukemia from 1990 to 2019: A systematic analysis of the global burden of disease in 2019 based on the APC model

  2024cites this paper
• Global burden due to modifiable risks factors for autoimmune diseases, 1990-2021: Temporal trends and socio-demographic inequalities.

  2024cites this paper
• Global and regional estimates of hip fracture burden associated with type 1 diabetes from 1990 to 2021

  2024cites this paper
• Burden of liver cancer attributable to high fasting plasma glucose: a global analysis based on the global burden of disease study 2019

  2024influential citation
• Estimates and trends of the global burden of NASH-related liver cancer attributable to high fasting plasma glucose in 1990–2019: analysis of data from the 2019 Global Burden of Disease Study

  2023cites this paper
• Global burden trends of MAFLD‐related liver cancer from 1990 to 2019

  2023cites this paper
• The burden of brain and central nervous system cancers in Asia from 1990 to 2019 and its predicted level in the next twenty-five years

  2023cites this paper
• Secular trends and attributable risk factors of esophageal cancer deaths among non-elderly adults based on Global Burden of Disease Study

  2023cites this paper
• A comparison of the burden of knee osteoarthritis attributable to high body mass index in China and globally from 1990 to 2019

  2023cites this paper
• The incidence of brain trauma caused by road injuries: Results from the Global Burden of Disease Study 2019.

  2023cites this paper
• Global Burden, Risk Factors Analysis, and Prediction Study of Ischemic Stroke, 1990-2030.

  2023cites this paper
• The trends in death of primary liver cancer caused by specific etiologies worldwide: results from the Global Burden of Disease Study 2019 and implications for liver cancer management

  2023cites this paper
• Global and regional estimates of cervical cancer burden associated with human immunodeficiency virus infection from 1990 to 2019

  2023cites this paper
• Microorganisms-derived antigens for preventive anti-cancer vaccines.

  2023cites this paper
• Geographical disparities in hepatitis b virus related hepatocellular carcinoma mortality rates worldwide from 1990 to 2019

  2023cites this paper
• Global burden and risk factors of musculoskeletal disorders among adolescents and young adults in 204 countries and territories, 1990-2019.

  2023cites this paper
• Development of hepatocellular carcinoma in treated and untreated patients with chronic hepatitis B virus infection

  2023cites this paper
• Trend of disease burden and risk factors of breast cancer in developing countries and territories, from 1990 to 2019: Results from the Global Burden of Disease Study 2019

  2023cites this paper
• Letter: vaccination for global control of hepatitis B—from prevention to elimination. Authorsʼ reply

  2022cites this paper
• National, regional, and global cardiomyopathy burden from 1990 to 2019

  2022cites this paper
• Global burden and trends of pelvic organ prolapse associated with aging women: An observational trend study from 1990 to 2019

  2022influential citation
• Child–Pugh Score and ABCG2-rs2231142 Genotype Independently Predict Survival in Advanced Hepatoma Patients Treated with Sorafenib

  2022cites this paper
• The Global Impact of Hepatitis B Vaccination on Hepatocellular Carcinoma

  2022influential citation
• Comparison of primary liver cancer mortality estimates from World Health Organization, global burden disease and global cancer observatory

  2022cites this paper
• Inflammatory Indexes as Prognostic Factors of Survival in Geriatric Patients with Hepatocellular Carcinoma: A Case Control Study of Eight Slovak Centers

  2022cites this paper
• Burden and Trends of IBD in 5 Asian Countries From 1990 to 2019: A Comparison With the United States and the United Kingdom

  2022cites this paper
• Hepatocellular carcinoma incidence is decreasing in Korea but increasing in the very elderly

  2022cites this paper
• The global burden of type 2 diabetes attributable to high body mass index in 204 countries and territories, 1990–2019: An analysis of the Global Burden of Disease Study

  2022cites this paper
• Burden of atrial fibrillation and its attributable risk factors from 1990 to 2019: An analysis of the Global Burden of Disease study 2019

  2022cites this paper
• Global, regional, and national burden of uterine fibroids in the last 30 years: Estimates from the 1990 to 2019 Global Burden of Disease Study

  2022cites this paper
• Letter: vaccination for global control of hepatitis B—from prevention to elimination

  2022cites this paper
• The global burden of periodontal diseases in 204 countries and territories from 1990 to 2019.

  2022cites this paper
• Global prediction of primary liver cancer incidences and mortality in 2040.

  2022cites this paper
• National, Regional, and Global Cardiomyopathy Burden from 1990 – 2019

  2022cites this paper
• The burden of liver cirrhosis in mortality: Results from the global burden of disease study

  2022cites this paper
• Prevention of hepatitis B virus-related hepatocellular carcinoma

  2021cites this paper
• Diagnosis experiences from 50 hepatitis B patients in Chongqing, China: a qualitative study

  2021cites this paper
• Temporal trends of carbon monoxide poisoning mortality at the global, regional and national levels: a cross-sectional study from the Global Burden of Disease study, 1990 and 2017

  2021cites this paper
• CIA_A_295524 1633..1649

  2021cites this paper
• LncRNA GAS5 enhances radiosensitivity of hepatocellular carcinoma and restricts tumor growth and metastasis by miR-144-5p/ATF2.

  2021cites this paper
• Impact of aging on primary liver cancer: epidemiology, pathogenesis and therapeutics

  2021cites this paper
• NAFLD in the Elderly

  2021cites this paper
• Global Burden of Disease Study 2019 suggests that metabolic risk factors are the leading drivers of the burden of ischemic heart disease.

  2021cites this paper
• Hepatocellular carcinoma statistics in South Korea

  2021cites this paper
• Global, regional, and national burden of biliary tract cancer from 1990 to 2017 based on the 2017 Global Burden of Disease study.

  2021cites this paper
• Current Trends and Characteristics of Hepatocellular Carcinoma in Patients with Autoimmune Liver Diseases

  2021cites this paper
• The incidence trends of liver cirrhosis caused by nonalcoholic steatohepatitis via the GBD study 2017

  2021cites this paper
• The impact of universal hepatitis B vaccine on the trend of liver cancer from the Global Burden of Disease Study 2017

  2021cites this paper
• Qualitative Interviews on The Diagnosis Process of Hepatitis B Among 50 Patients in Chongqing, China

  2021cites this paper
• Changing risk factors for hepatocellular carcinoma in hyperendemic regions in the era of universal hepatitis B vaccination.

  2020cites this paper
• Global trends in the incidence and mortality of esophageal cancer from 1990 to 2017

  2020cites this paper
• Descriptive epidemiology of incidence and mortality of primary liver cancer in 185 countries: evidence from GLOBOCAN 2018.

  2020cites this paper
• Lifestyle and Cancer Prevention

  2020cites this paper
• Hepatocellular carcinoma in Ghana: a retrospective analysis of a tertiary hospital data

  2020cites this paper
• In silico designing of peptide based vaccine for Hepatitis viruses using reverse vaccinology approach.

  2020cites this paper
• Hepatitis B: Immunization and Impact on Natural History and Cancer Incidence.

  2020cites this paper
• Preventing Lethal Prostate Cancer with Diet, Supplements, and Rx: Heart Healthy Continues to Be Prostate Healthy and “First Do No Harm” Part III

  2020cites this paper
• Global trends in incidence rates of childhood liver cancers: A systematic review and meta-analysis.

  2020cites this paper
• Global Trends in Incidence Rates of Primary Adult Liver Cancers: A Systematic Review and Meta-Analysis

  2020cites this paper
• The burden of liver cirrhosis and underlying etiologies: results from the global burden of disease study 2017

  2020cites this paper
• The Burden of Liver Cirrhosis in Mortality: Results from the Global Burden of Disease Study 2017

  2020cites this paper
• Gamma-glutamyl transpeptidase-to-platelet ratio and the fibrosis-4 index in predicting hepatitis B virus-related hepatocellular carcinoma development in elderly chronic hepatitis B patients in China

  2019influential citation
• Trends in the incidence of diabetes mellitus: results from the Global Burden of Disease Study 2017 and implications for diabetes mellitus prevention

  2019cites this paper
• The trends in incidence of primary liver cancer caused by specific etiologies: Results from the Global Burden of Disease Study 2016 and implications for liver cancer prevention.

  2019cites this paper
• Global burden of breast cancer and attributable risk factors in 195 countries and territories, from 1990 to 2017: results from the Global Burden of Disease Study 2017

  2019cites this paper
• Integrated analysis of the impact of age on genetic and clinical aspects of hepatocellular carcinoma

  2018cites this paper
• Modulation of dietary folate with age confers selective hepatocellular epigenetic imprints through DNA methylation.

  2018cites this paper
• Preventing Lethal Prostate Cancer with Diet, Supplements, and Rx: Heart Healthy Continues to Be Prostate Healthy and “First Do No Harm” Part I

  2018cites this paper
• Hepatoblastoma incidence in Taiwan: A population‐based study

  2018cites this paper
• Review article: the prevention of hepatitis B‐related hepatocellular carcinoma

  2018cites this paper
• Hepatocellular Carcinoma in Children and Adolescents: Clinical Characteristics and Treatment

  2017cites this paper
• Management and prognosis of hepatocellular carcinoma in the elderly: Results of an in‐field multicenter cohort study

  2017cites this paper
• Mortality from cirrhosis and hepatocellular carcinoma in Western Europe over the last 40 years

  2017cites this paper
• Viral Hepatitis

  2017cites this paper
• Deciphering the epidemiology of hepatocellular carcinoma through the passage of time: A study of 1,401 patients across 3 decades

  2017cites this paper
• Management consensus guideline for hepatocellular carcinoma: 2016 updated by the Taiwan Liver Cancer Association and the Gastroenterological Society of Taiwan.

  2017cites this paper
• Cancer in adolescents: Incidences and trends during 1995-2009 in Taiwan.

  2016cites this paper
• Global burden of cancers attributable to infections in 2012: a synthetic analysis.

  2016cites this paper
• Hepatocellular carcinoma and antidepressants: a nationwide population-based study

  2016cites this paper
• Incidence of cholangiocarcinoma and prevalence of opisthorchis viverrini infestation in Songkhla province, Southern Thailand

  2016cites this paper
• Estimation of the Incidence of Hepatocellular Carcinoma and Cholangiocarcinoma in Songkhla, Thailand, 1989-2013, Using Multiple Imputation Method

  2016cites this paper
• Malignant tumors of the liver in children.

  2016cites this paper
• Universal hepatitis B vaccination: The only way to eliminate hepatocellular carcinoma?

  2015cites this paper